| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |